Shares of Mankind Pharma dropped 5.5% following news of India’s income tax department conducting searches at its Delhi office. Its shares are still trading 4.8% above its listing price which was offered at Rs 1,080. Earlier this week, brokerage firm Antique initiated coverage of Mankind Pharma with a Buy rating and a target of Rs 1,584.
Subscribe To Our Free Newsletter |